Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

18 in total

1. Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse.

Authors: Andrew Kent; Sumithira Vasu; Derek Schatz; Natalie Monson; Steven Devine; Clayton Smith; Jonathan A Gutman; Daniel A Pollyea
Journal: Blood Adv Date: 2020-07-14

Review 2. Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Authors: Christopher R Cogle; Bart L Scott; Thomas Boyd; Guillermo Garcia-Manero
Journal: Oncologist Date: 2015-10-13

Review 3. Histamine dihydrochloride: in the management of acute myeloid leukaemia.

Authors: Lily P H Yang; Caroline M Perry
Journal: Drugs Date: 2011-01-01 Impact factor: 9.546

4. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

Authors: Hagop M Kantarjian; Xavier G Thomas; Anna Dmoszynska; Agnieszka Wierzbowska; Grzegorz Mazur; Jiri Mayer; Jyh-Pyng Gau; Wen-Chien Chou; Rena Buckstein; Jaroslav Cermak; Ching-Yuan Kuo; Albert Oriol; Farhad Ravandi; Stefan Faderl; Jacques Delaunay; Daniel Lysák; Mark Minden; Christopher Arthur
Journal: J Clin Oncol Date: 2012-06-11 Impact factor: 44.544

Review 5. Spotlight on histamine dihydrochloride in acute myeloid leukaemia.

Authors: Lily P H Yang; Caroline M Perry
Journal: Drugs Aging Date: 2011-04-01 Impact factor: 3.923

Review 6. Lenalidomide: a review of its use in patients with transfusion-dependent anaemia due to low- or intermediate-1-risk myelodysplastic syndrome associated with 5q chromosome deletion.

Authors: Yahiya Y Syed; Lesley J Scott
Journal: Drugs Date: 2013-07 Impact factor: 9.546

7. Acute myelogenous leukemia at Baylor Charles A. Sammons Cancer Center, 2010 to 2012: retrospective analysis of molecular genetic evaluation.

Authors: Catherine Jones; Temekka V LeDay; Alan M Miller
Journal: Proc (Bayl Univ Med Cent) Date: 2014-10

Review 8. Decitabine: a review of its use in older patients with acute myeloid leukaemia.

Authors: Monique P Curran
Journal: Drugs Aging Date: 2013-06 Impact factor: 3.923

Review 9. Thrombopoietin mimetics for patients with myelodysplastic syndromes.

Authors: Helga Dodillet; Karl-Anton Kreuzer; Ina Monsef; Nicole Skoetz
Journal: Cochrane Database Syst Rev Date: 2017-09-30

10. Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial.

Authors: John Porter; Donald K Bowden; Marina Economou; Jacques Troncy; Arnold Ganser; Dany Habr; Nicolas Martin; Adam Gater; Diana Rofail; Linda Abetz-Webb; Helen Lau; Maria Domenica Cappellini
Journal: Anemia Date: 2012-08-12